TNSN99225A1 - Formulations de doramectine antiparasitaires et procede pour leur preparation - Google Patents
Formulations de doramectine antiparasitaires et procede pour leur preparationInfo
- Publication number
- TNSN99225A1 TNSN99225A1 TNTNSN99225A TNSN99225A TNSN99225A1 TN SN99225 A1 TNSN99225 A1 TN SN99225A1 TN TNSN99225 A TNTNSN99225 A TN TNSN99225A TN SN99225 A TNSN99225 A TN SN99225A TN SN99225 A1 TNSN99225 A1 TN SN99225A1
- Authority
- TN
- Tunisia
- Prior art keywords
- doramectin
- preparation
- formulations
- pest control
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
L'INVENTION CONCERNE UNE FORMULATION COMPRENANT DE LA DORAMECTINE DANS UN SOLVANT COMPRENANT DE L'HUILE DE RICIN ET DE L'OLEATE D'ETHYLE OU DE L'HUILE DE COPRAH FRACTIONNEE ET DES AGENTS AUXILIAIRES SUPPLEMENTAIRES FACULTATIFS. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE FORMULATION POUR LUTTER CONTRE DES ENDO-OU ECTOPARASITES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827727.0A GB9827727D0 (en) | 1998-12-16 | 1998-12-16 | Antiparasitic formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN99225A1 true TNSN99225A1 (fr) | 2005-11-10 |
Family
ID=10844352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN99225A TNSN99225A1 (fr) | 1998-12-16 | 1999-11-29 | Formulations de doramectine antiparasitaires et procede pour leur preparation |
Country Status (21)
Country | Link |
---|---|
US (1) | US6699847B2 (fr) |
EP (1) | EP1140068B1 (fr) |
JP (1) | JP3848537B2 (fr) |
AP (1) | AP9901699A0 (fr) |
AR (1) | AR019499A1 (fr) |
AT (1) | ATE269074T1 (fr) |
AU (1) | AU762892B2 (fr) |
BR (1) | BR9916265A (fr) |
CA (1) | CA2355102C (fr) |
DE (1) | DE69918165T2 (fr) |
DK (1) | DK1140068T3 (fr) |
ES (1) | ES2221455T3 (fr) |
GB (1) | GB9827727D0 (fr) |
GT (1) | GT199900213A (fr) |
MA (1) | MA26710A1 (fr) |
PA (1) | PA8486601A1 (fr) |
PE (1) | PE20001244A1 (fr) |
PT (1) | PT1140068E (fr) |
TN (1) | TNSN99225A1 (fr) |
TW (1) | TW524691B (fr) |
WO (1) | WO2000035445A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003257778A1 (en) * | 2002-08-02 | 2004-02-23 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | A riboflavin derivative and its manufacture and uses |
AU2003235019A1 (en) * | 2003-08-17 | 2005-03-03 | Sirene Call Pty Ltd | Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle |
NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
MX2009001235A (es) * | 2008-09-19 | 2010-04-29 | Agrovet Market S A | Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina. |
PL2396006T3 (pl) | 2009-02-16 | 2013-06-28 | Zoetis Llc | Preparat zawierający doramektynę w dużej dawce |
CN103417477B (zh) * | 2012-05-18 | 2015-08-05 | 中国农业科学院兰州畜牧与兽药研究所 | 一种以水为基质的多拉菌素o/w型注射液及其制备方法 |
CN104822299B (zh) | 2012-11-09 | 2018-11-20 | 伊莱克斯公司 | 拌合器 |
EA037747B1 (ru) * | 2019-04-01 | 2021-05-18 | Севиндж Аллахверди кызы АЛИЕВА | Антипаразитарное средство |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL151903B (nl) | 1965-03-24 | 1977-01-17 | Schering Ag | Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat. |
DE3377064D1 (en) | 1982-12-28 | 1988-07-21 | Bayer Ag | Stable aminoglycoside-penicillin injection formulation |
DE3484584D1 (de) | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | Injektionen mit verzoegerter abgabe. |
CA1285874C (fr) | 1985-08-23 | 1991-07-09 | Thomas Harry Ferguson | Formule injectable a liberation soutenue |
ES2052173T3 (es) | 1989-04-11 | 1994-07-01 | Pfizer | Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. |
NZ234802A (en) | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
ATE180671T1 (de) | 1991-09-30 | 1999-06-15 | Merck & Co Inc | Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe |
DE4410970C1 (de) | 1994-03-29 | 1995-07-20 | Talbot Waggonfab | Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung |
US5580574A (en) | 1994-04-28 | 1996-12-03 | Hoffmann-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
WO1997011709A1 (fr) * | 1995-09-25 | 1997-04-03 | Ashmont Holdings Limited | Compositions anthelmintiques a base de lactone macrocyclique |
DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
-
1998
- 1998-12-16 GB GBGB9827727.0A patent/GB9827727D0/en not_active Ceased
-
1999
- 1999-11-22 ES ES99954291T patent/ES2221455T3/es not_active Expired - Lifetime
- 1999-11-22 AT AT99954291T patent/ATE269074T1/de active
- 1999-11-22 PT PT99954291T patent/PT1140068E/pt unknown
- 1999-11-22 BR BR9916265-2A patent/BR9916265A/pt not_active Application Discontinuation
- 1999-11-22 CA CA002355102A patent/CA2355102C/fr not_active Expired - Fee Related
- 1999-11-22 EP EP99954291A patent/EP1140068B1/fr not_active Expired - Lifetime
- 1999-11-22 DK DK99954291T patent/DK1140068T3/da active
- 1999-11-22 JP JP2000587765A patent/JP3848537B2/ja not_active Expired - Fee Related
- 1999-11-22 AU AU10699/00A patent/AU762892B2/en not_active Ceased
- 1999-11-22 WO PCT/IB1999/001854 patent/WO2000035445A1/fr active IP Right Grant
- 1999-11-22 DE DE69918165T patent/DE69918165T2/de not_active Expired - Lifetime
- 1999-11-22 AP APAP/P/1999/001699A patent/AP9901699A0/en unknown
- 1999-11-23 TW TW088120463A patent/TW524691B/zh active
- 1999-11-24 PE PE1999001183A patent/PE20001244A1/es not_active Application Discontinuation
- 1999-11-26 AR ARP990106036A patent/AR019499A1/es active IP Right Grant
- 1999-11-29 TN TNTNSN99225A patent/TNSN99225A1/fr unknown
- 1999-11-30 MA MA25859A patent/MA26710A1/fr unknown
- 1999-12-07 PA PA19998486601A patent/PA8486601A1/es unknown
- 1999-12-15 GT GT199900213A patent/GT199900213A/es unknown
-
2001
- 2001-11-07 US US10/039,608 patent/US6699847B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE269074T1 (de) | 2004-07-15 |
PE20001244A1 (es) | 2000-11-07 |
ES2221455T3 (es) | 2004-12-16 |
PA8486601A1 (es) | 2000-09-29 |
US6699847B2 (en) | 2004-03-02 |
MA26710A1 (fr) | 2004-12-20 |
WO2000035445A1 (fr) | 2000-06-22 |
BR9916265A (pt) | 2001-11-20 |
JP3848537B2 (ja) | 2006-11-22 |
AU1069900A (en) | 2000-07-03 |
DK1140068T3 (da) | 2004-07-12 |
US20020142972A1 (en) | 2002-10-03 |
DE69918165T2 (de) | 2004-10-14 |
CA2355102C (fr) | 2006-07-11 |
TW524691B (en) | 2003-03-21 |
DE69918165D1 (de) | 2004-07-22 |
GT199900213A (es) | 2001-06-07 |
JP2002532422A (ja) | 2002-10-02 |
AP9901699A0 (en) | 2001-05-22 |
EP1140068B1 (fr) | 2004-06-16 |
AR019499A1 (es) | 2002-02-20 |
GB9827727D0 (en) | 1999-02-10 |
CA2355102A1 (fr) | 2000-06-22 |
PT1140068E (pt) | 2004-09-30 |
EP1140068A1 (fr) | 2001-10-10 |
AU762892B2 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA25029A1 (fr) | Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation. | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
ATE300533T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
TNSN99172A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
BE2015C026I2 (en) | 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens | |
DE69625374D1 (en) | (methylsulfonyl)phenyl-2-(5h)-furanone als cox-2 inhibitoren | |
TR200102817T2 (tr) | Antiinflamatuar ajanlar olarak faydalı bileşikler | |
DE3176125D1 (en) | 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds | |
DE69935335D1 (de) | Pyrazole als modulatoren des östrogenrezeptors | |
TNSN99125A1 (fr) | Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
BR9611096B1 (pt) | composição farmacêutica compreendendo um extrato estável de hypericum perforatum l. | |
WO1997030677A3 (fr) | Pentafluorobenzenesulfonamides et analogues | |
HK1028548A1 (en) | Formulations for hydrophobic pharmaceutical agents | |
CA2330500A1 (fr) | Compositions pharmaceutiques gelifiables | |
DE60138709D1 (de) | Analoge der barbitursäure als therapeutische wirkstoffe | |
DE69618820D1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
TNSN99225A1 (fr) | Formulations de doramectine antiparasitaires et procede pour leur preparation | |
AP9801269A0 (en) | Prostaglandin agonists. | |
CA2255229A1 (fr) | Utilisation de l'acide cinnamique ou de ses derives dans une composition cosmetique raffermissante | |
EP0953331A3 (fr) | Composition anhydre fluorée et produits cosmétiques ou de soins la contenant | |
TNSN01052A1 (fr) | Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant | |
WO2004055201A3 (fr) | Cholesterol 24-hydroxylase (cyp46) utilisee en tant que cible therapeutique pour le traitement de la maladie d'alzheimer | |
ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
DE69715173D1 (en) | Bisarylcyclobutenderivate als cyclooxygenasehemmer |